Prognosis in Guillain-Barre syndrome.

Briscoe, David M.; McMenamin, Joseph B.; O'Donohoe, N. V.

doi:10.1136/adc.62.7.733

Cited by 50 publications

(31 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…By contrast, only one of 23 children with GBS reported by Briscoe et al 12 required ventilation, as did 16% of patients reported by Korinthenberg and Schulte Monting 11. In a report of 11 paediatric patients with severe GBS,13 the nine patients who survived were ventilated for a median of 18 days, whereas the median duration of ventilation reported in a multicentre study was 10 days 11…”

Section: Discussionmentioning

confidence: 88%

Campylobacter 0:41 isolation in Guillain-Barre syndrome

Goddard

Lastovica

Argent

1997

Archives of Disease in Childhood

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 88%

Campylobacter 0:41 isolation in Guillain-Barre syndrome

Goddard

Lastovica

Argent

1997

Archives of Disease in Childhood

View full text Add to dashboard Cite

show abstract

“…19,23 Inexicitablity can result either from axonal degeneration or dysfunction or demyelination causing complete conduction block. 24 Other factors predicting poor outcome include, a protracted plateau time, change to chronic progressive or relapsing neuropathy 10,16 or concurrent myelitis. 16 A longer time to independent walking was an indicator of poorer long term recovery in the present series.…”

Section: Resultsmentioning

confidence: 99%

Outcome in childhood Guillain-Barré syndrome

et al. 2009

View full text Add to dashboard Cite

show abstract

“…This syndrome is very severe, leading to a 2 to 3% mortality and major neurological sequelae in 20% of the cases. The other patients experience a partial or total recovery [22]. The most severe cases are induced by C. jejuni [77,183].…”

Section: Post-infectious Manifestationsmentioning

confidence: 99%

Campylobacter

et al. 2005

View full text Add to dashboard Cite

-Species within the genus, Campylobacter, have emerged over the last three decades as significant clinical pathogens, particularly of human public health concern, where the majority of acute bacterial enteritis in the Western world is due to these organisms. Of particular concern are the species, C. jejuni and C. coli, which are responsible for most of these gastrointestinal-related infections. Although these organisms have already emerged as causative agents of zoonoses, several aspects of their epidemiology and pathophysiology are only beginning to emerge. Trends in increasing antibiotic resistance are beginning to emerge with oral antibiotics, which may be the drug of choice for when it is necessary to intervene chemotherapeutically. This review wishes to examine (i) emerging clinical aspects of the disease, such as Guillain Barré syndrome (GBS), (ii) the association between these organisms and poultry as a natural host, (iii) environmental aspects of Campylobacter epidemiology, (iv) the emergence of atypical campylobacters (v) emerging trends in antibiotic resistance, (vi) adoption of modern methods for the detection of campylobacters.

show abstract

Prognosis in Guillain-Barre syndrome.

Cited by 50 publications

References 8 publications

Campylobacter 0:41 isolation in Guillain-Barre syndrome

Campylobacter 0:41 isolation in Guillain-Barre syndrome

Outcome in childhood Guillain-Barré syndrome

Campylobacter

Contact Info

Product

Resources

About